Showing results (1061-1070 of 1,129) with videos related to
Sort By:
Pageof 113
Journal of Hematology & Oncology|March 8, 2022
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trialKe Zhao, Ren Lin, Zhiping Fan, et al.Plos One|October 8, 2013
Comparison of three intervention models for promoting circumcision among migrant workers in western China to reduce local sexual transmission of HIVChuanyi Ning, Junjun Jiang, Li Ye, et al.The Lancet Regional Health. Western Pacific|August 20, 2025
Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trialQifa Liu, Zhongli Hu, Na Xu, et al.AIDS Research and Human Retroviruses|December 6, 2012
Prevalence and correlates of sexual risk behaviors among drug users in western China: implications for HIV transmissionJiegang Huang, Junjun Jiang, Jonathan Z Li, et al.Frontiers in Oncology|February 13, 2019
Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivoLi-Na Xu, Na Zhao, Jin-Yan Chen, et al.Atherosclerosis|November 10, 2022
Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary interventionDeshan Yuan, Peizhi Wang, Sida Jia, et al.Frontiers in Plant Science|January 30, 2023
High-resolution quantitative trait locus mapping for rice grain quality traits using genotyping by sequencingSu-Kui Jin, Li-Na Xu, Qing-Qing Yang, et al.The Lancet. Haematology|January 26, 2023
The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trialLi Xuan, Min Dai, Erlie Jiang, et al.Vaccines|November 11, 2022
Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled StudyLi Li, Nianmin Shi, Na Xu, et al.Elife|January 14, 2026
Fish CDK2 recruits Dtx4 to degrade TBK1 through ubiquitination in the antiviral responseLong-Feng Lu, Can Zhang, Zhuo-Cong Li, et al.Pageof 113